Home›Companies›Healthcare›Aerwave Medical

Aerwave Medical, Inc.

Updated Oct 27, 2026·Latest SEC filing Aug 17, 2023·Suggest an edit

About Aerwave Medical

Aerwave Medical is a private company based in Naples, Florida, incorporated in 2020 in Delaware. It has reported $5,480,195 raised in two offerings on Form D since January 2021. Its chief executive is Jeffrey O'Donnell.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jun 27, 2022Jul 15, 2022amended Aug 17, 2023$3,965,195of $5.0M target58$68,365Equity, DebtRule 506(b)Form D/A ↗1 earlier filing
Jan 13, 2021Jan 28, 2021$1,515,000of $4.0M target14$108KEquity, OptionsRule 506(b)Form D ↗
Total, two offerings$5,480,195

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Aerwave Medical's Form D filed Aug 17, 2023.

TH
Tony Hodges
Director
MD
Matthew Duffy
Director
Also a director at Algorithm Sciences, a president, treasurer, secretary and director at PD Theranostics and a president and director at Voltron Therapeutics.
RW
Reinhard Warnking
Executive officer and director
JD
Jeffrey O'Donnell
CEO and director
Also a director at Algorithm Sciences.
PG
Patrick Gallagher
Director
Also a director at Algorithm Sciences and a chief executive officer and director at PD Theranostics and Voltron Therapeutics.
CC
Craig Carra
Director

Sources

  1. SECAerwave Medical, Inc. Form D, filed Jul 15, 2022
  2. SECAerwave Medical, Inc. filing history